Troponin Elevation in Consecutive Patients With Hip Fracture
Completed
- Conditions
- Hip Fracture
- Registration Number
- NCT01015105
- Lead Sponsor
- Turku University Hospital
- Brief Summary
The aims of this study is to study the occurrence of the troponin elevations, ECG changes, and cardiac symptoms in unselected consecutive patients with hip fracture.
Followup will be carried out up to one year period.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link troponin elevation to cardiac events in hip fracture patients?
How does troponin elevation in hip fracture patients compare to standard-of-care outcomes for cardiovascular risk assessment?
Which biomarkers correlate with troponin elevation and cardiac complications in elderly hip fracture patients?
What adverse cardiac events are associated with troponin elevation in hip fracture patients and how are they managed?
Are there specific drug classes or combination therapies that mitigate cardiac risks in hip fracture patients with elevated troponin?
Trial Locations
- Locations (1)
Turku University Hospital
🇫🇮Turku, Finland
Turku University Hospital🇫🇮Turku, Finland